Bachy CM - Search Results

1

Analysis of human and primate CD2 molecules by protein sequence and epitope mapping with anti-human CD2 antibodies.

Damschroder MM, Kozhich AA, Woods RM, Cheng L, Mullikin BA, Wilson SD, Ulbrandt ND, Bachy CM, Wu H, Suzich JA, Kiener PA, Dall'Acqua WF, White WI. Damschroder MM, et al. Among authors: bachy cm. Mol Immunol. 2004 Aug;41(10):985-1000. doi: 10.1016/j.molimm.2004.05.004. Mol Immunol. 2004. PMID: 15302161

2

Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies.

Ulbrandt ND, Cassatt DR, Patel NK, Roberts WC, Bachy CM, Fazenbaker CA, Hanson MS. Ulbrandt ND, et al. Among authors: bachy cm. Infect Immun. 2001 Aug;69(8):4799-807. doi: 10.1128/IAI.69.8.4799-4807.2001. Infect Immun. 2001. PMID: 11447153 Free PMC article.

3

Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure.

Cassatt DR, Fazenbaker CA, Bachy CM, Kifle G, McCarthy MP. Cassatt DR, et al. Among authors: bachy cm. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):901-7. doi: 10.1016/j.ijrobp.2004.10.032. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708273

4

Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy.

Cassatt DR, Fazenbaker CA, Bachy CM, Hanson MS. Cassatt DR, et al. Among authors: bachy cm. Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):97-102. doi: 10.1053/srao.2002.31382. Semin Radiat Oncol. 2002. PMID: 11917293

5

Subcutaneous administration of amifostine (ethyol) is equivalent to intravenous administration in a rat mucositis model.

Cassatt DR, Fazenbaker CA, Kifle G, Bachy CM. Cassatt DR, et al. Among authors: bachy cm. Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):794-802. doi: 10.1016/s0360-3016(03)00660-6. Int J Radiat Oncol Biol Phys. 2003. PMID: 14529786

6

Effects of dose and schedule on the efficacy of ethyol: preclinical studies.

Cassatt DR, Fazenbaker CA, Kifle G, Bachy CM. Cassatt DR, et al. Among authors: bachy cm. Semin Oncol. 2003 Dec;30(6 Suppl 18):31-9. doi: 10.1053/j.seminoncol.2003.11.039. Semin Oncol. 2003. PMID: 14727238 Review.

7

Tissue levels of WR-1065, the active metabolite of amifostine (Ethyol), are equivalent following intravenous or subcutaneous administration in cynomolgus monkeys.

Bachy CM, Fazenbaker CA, Kifle G, McCarthy MP, Cassatt DR. Bachy CM, et al. Oncology. 2004;67(3-4):187-93. doi: 10.1159/000081316. Oncology. 2004. PMID: 15557777

8

Preclinical studies on the radioprotective efficacy and pharmacokinetics of subcutaneously administered amifostine.

Cassatt DR, Fazenbaker CA, Kifle G, Bachy CM. Cassatt DR, et al. Among authors: bachy cm. Semin Oncol. 2002 Dec;29(6 Suppl 19):2-8. doi: 10.1053/sonc.2002.37355. Semin Oncol. 2002. PMID: 12577236 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters